A
Allied Corp
OTC:ALID
Allied Corp
OTC:ALID
Price:
0.0005
USD
Market Closed
Market Cap:
$115.5
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Allied Corp
OTC:ALID
|
CA |
|
Fellow Pankki Oyj
LSE:0RD4
|
FI |
|
Tim SA
BOVESPA:TIMS3
|
BR |
|
Transgene Biotek Ltd
BSE:526139
|
IN |
|
I
|
Imperial Ginseng Products Ltd
XTSX:IGP
|
CA |
|
B
|
Boldtek Holdings Ltd
SGX:5VI
|
SG |
|
I
|
Israel Acquisitions Corp
NASDAQ:ISRL
|
US |
|
Brooks Macdonald Group PLC
LSE:BRK
|
UK |
|
Sirca Paints India Ltd
NSE:SIRCA
|
IN |
|
36Kr Holdings Inc
NASDAQ:KRKR
|
CN |
|
Arrowmark Financial Corp
NASDAQ:BANX
|
US |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of ALID.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALID
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
ALID Competitors Multiples
Allied Corp Competitors
Allied Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
A
|
Allied Corp
OTC:ALID
|
115.5 USD | 0 | -0 | -2.5 | -2.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118B USD | 2.5 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
